Klencke Barbara
SEC CIK 1647647 · EDGAR
BoughtSold
Most active insiders at XNCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dahiyat Bassil I | Pres, CEO, Dir | — | $2.12M |
| 2 | Desjarlais John R | CSO, SR. VP | — | $1.26M |
| 3 | GORMAN KEVIN CHARLES | Dir | — | $92.7K |
| 4 | Feigal Ellen | Dir | — | $89.4K |
| 5 | Eckert Celia | SVP, GC | — | $73.7K |
| 6 | Cornelissen Bart Jan | CFO, SR. VP | — | $71.3K |
| 7 | GUSTAFSON KURT A | Dir | — | $67.4K |
| 8 | RANIERI RICHARD J | Dir | — | $67.4K |
| 9 | Montgomery Alan Bruce | Dir | — | $62.3K |
| 10 | Deshaies Raymond Joseph | Dir | — | — |
| 11 | Klencke Barbara | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-08 18:54 | 2026-06-16 | XNCR | Xencor Inc | Klencke Barbara | Dir | A - Grant | $0.00 | +10.3K | 30.0K | +52% | $0 |
| D | 2025-06-16 | 2025-06-12 | XNCR | Xencor Inc | Klencke Barbara | Dir | A - Grant | $0.00 | +13.7K | 19.7K | +229% | $0 |
| 2024-09-24 | 2024-09-23 | TCRX | TScan Therapeutics, Inc. | Klencke Barbara | Dir | P - Purchase | $5.29 | +5,000 | 45.0K | +12% | +$26.4K | |
| M | 2024-08-27 | 2024-08-23+ | TCRX | TScan Therapeutics, Inc. | Klencke Barbara | Dir | P - Purchase | $5.61 | +10.0K | 35.0K | +40% | +$56.1K |
| D | 2024-06-17 | 2024-06-13 | XNCR | Xencor Inc | Klencke Barbara | Dir | A - Grant | $0.00 | +5,986 | 5,986 | New | $0 |
| 2023-12-18 | 2023-12-14 | TCRX | TScan Therapeutics, Inc. | Klencke Barbara | Dir | P - Purchase | $5.08 | +5,000 | 30.0K | +20% | +$25.4K |
Purchase Sale Sale after option exercise All abbreviations